COA Community Oncology Conference 2024

Empowering Community Oncology: Advancing cancer care where it matters most.

COA Banner



A hospital administrator shows a doctor something on a tablet<br>

Business Track

As a fierce advocate for community oncology, we bring proven know-how and tailored solutions that help you better manage the challenges of rising drug costs, improve your financial outlook, and handle administrative issues more easily so that you can focus on maintaining high-quality care for your patients. Find out more:

Glide: Improving Claims Acceptance Rates

Watch: Supercharge your billing workflow with Glide Health

Get support with practice management and more

Watch: Community Oncology in Action

A doctor consulting with a patient

Clinical Track

As the healthcare landscape continues to evolve, payers are requiring providers to shift the way they provide care and run their businesses. The shift from volume-based care to value-based reimbursement is designed to drive better care for patients at an affordable cost.

With us by your side, you’ll have the tools, best practices, and expertise you need to deliver quality care to your patients at a lower cost – learn how:

Value-Based Care and Quality Payment Programs for Specialty Practices

Hands-On Support for Value-Based Care

E-Book: 8 Factors for Success in the Transition to Value-Based Care

Pharmacy Track

Our drug distribution and group purchasing organization streamlines operations and helps manage costs for community oncology practices. With a focus on providing efficient, cost-effective drug supply solutions, we support practices in delivering quality patient care without the burden of managing complex procurement processes. Our track record in drug distribution underlines our commitment to reliable support for independent providers. Learn more:

Oncology Practice Solutions

Onmark Group Purchasing Organization (GPO) Services

Comprehensive Solutions to Drive Managed Care Oncology Financial Security

Combatting Drug Shortages

Access to Oncology and Rare and Orphan Therapies